Patents : |  |
| US Patent No. | Title |
| 7608411 | Prostaglandin receptor EP1
|
| 7611893 | Metal-binding therapeutic peptides
|
| 7611910 | Method for diagnosis of alzheimer's disease
|
| 7612032 | Method for treating oncological diseases
|
| 7612033 | Methods for delivering compounds into a cell
|
| 7612044 | Melanoma antigens and their use in diagnostic and therapeutic methods
|
| 7612092 | Nitrogen-containing aromatic derivatives
|
| 7612093 | Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy
|
| 7612107 | Treatment and inhibition of disease conditions using flexible heteroarotinoids
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
| 7612208 | Crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinoli- necarboxamide or the solvate of the salt and a process for preparing the same
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7611857 | IL-receptor like molecules and uses thereof
|
| 7611711 | VEGFR-3 inhibitor materials and methods
|
| 7608452 | Polynucleotides encoding cytokine receptor zcytor19
|
| 7608618 | Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1
|
| 7608635 | Pyrazole compounds that modulate HSP90 activity
|
| 7608643 | Compounds for inhibiting KSP kinesin activity
|
| 7608704 | Secreted proteins
|
| 7608723 | Indole and benzimidazole derivatives
|
| 7608739 | Mitotic kinesin inhibitors
|
| 7608749 | Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
|
| 7611700 | Protease resistant modified interferon alpha polypeptides
|
| 7611704 | Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
|
| 7612213 | Compound having antitumor activity and process for producing the same
|
| 7615209 | Compositions of NDV and methods of use thereof for treatment of cancer
|
| 7618943 | Fusion polypeptides, and use thereof in antivascular tumor therapy
|
| 7618947 | Modulation of HIF-1 beta expression
|
| 7618965 | (Arylamidoanilino)nitroethylene compounds
|
| 7618971 | Mitotic kinesin inhibitors
|
| 7618975 | 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
| 7618981 | Imidazopyridinyl-benzamide anti-cancer agents
|
| 7618982 | Heteroarylpyrrolopyridinones active as kinase inhibitors
|
| 7618984 | Sulfonamide compound
|
| 7619006 | Conjugated psychotropic drugs and uses thereof
|
| 7619057 | MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
|
| 7618816 | Metal-binding therapeutic peptides
|
| 7618791 | Methods of detecting cancer with antibodies to cytokine receptor ZCYTOR19
|
| 7618787 | Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelarator and apoptosis inhibitor
|
| 7615223 | Selected immunoconjugates for binding to aminophospholipids
|
| 7615372 | Antibodies with immune effector activity and that internalize in endosialin-positive cells
|
| 7615380 | Methods for modulating an immune response by modulating KRC activity
|
| 7615611 | Human cytokine receptor
|
| 7615618 | Oligonucleotides comprising a non-phosphate backbone linkage
|
| 7615628 | Imidazopyridine derivatives
|
| 7618621 | Mammalian multipotent neural stem cells and compositions, methods of preparation and methods of administration thereof
|
| 7618622 | Treatment of Parkinson's disease and related disorders using postpartum derived cells
|
| 7618632 | Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies
|
| 7618785 | Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
|
| 7619065 | Cystine-knot fold protein
|
